Paolo Tarantino
@ptarantinomd
MD, PhD, Medical Oncologist | Clinical Fellow @DanaFarber | @Harvard. SoMe Editor @ESMO_Open. Interested in breast oncology, HER2, ADCs and good music.
ID: 958742483856486400
31-01-2018 16:43:15
13,13K Tweet
26,26K Followers
651 Following
What once was a future horizon is now the present shore: HER2 ultralow is a new targetable entity. Yet we’re only halfway the navigation of the HER2 paradigm. Enhanced methods for the quantitation of HER2 & prediction of ADC activity lie ahead. Stay tuned. aacrjournals.org/cancerdiscover…
